| pubmed-article:6378753 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6378753 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:6378753 | lifeskim:mentions | umls-concept:C0033325 | lld:lifeskim |
| pubmed-article:6378753 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:6378753 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:6378753 | lifeskim:mentions | umls-concept:C0684224 | lld:lifeskim |
| pubmed-article:6378753 | lifeskim:mentions | umls-concept:C0024305 | lld:lifeskim |
| pubmed-article:6378753 | lifeskim:mentions | umls-concept:C0231221 | lld:lifeskim |
| pubmed-article:6378753 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:6378753 | lifeskim:mentions | umls-concept:C0205265 | lld:lifeskim |
| pubmed-article:6378753 | lifeskim:mentions | umls-concept:C1555582 | lld:lifeskim |
| pubmed-article:6378753 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:6378753 | pubmed:dateCreated | 1984-9-20 | lld:pubmed |
| pubmed-article:6378753 | pubmed:abstractText | Thirty-one (58 per cent) of a group of fifty-three unselected patients with stage II-IV favourable prognosis non-Hodgkin's lymphoma were regarded as being eligible for a prospective study of no initial therapy. Seventeen of these patients (55 per cent) have required no treatment for periods from 6 + -47 + months, (median 18 months) and fourteen patients have been treated with chemotherapy for progressive disease after a period varying from 3-40 months (median 9.5 months). Selected asymptomatic patients with non-bulky disease may be suitable for no initial therapy. Randomized prospective trials will be needed to test whether survival is affected by delaying therapy. | lld:pubmed |
| pubmed-article:6378753 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6378753 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6378753 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6378753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6378753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6378753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6378753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6378753 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6378753 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6378753 | pubmed:issn | 0278-0232 | lld:pubmed |
| pubmed-article:6378753 | pubmed:author | pubmed-author:RyallR DRD | lld:pubmed |
| pubmed-article:6378753 | pubmed:author | pubmed-author:WhitehouseJ... | lld:pubmed |
| pubmed-article:6378753 | pubmed:author | pubmed-author:WilliamsC JCJ | lld:pubmed |
| pubmed-article:6378753 | pubmed:author | pubmed-author:MeadG MGM | lld:pubmed |
| pubmed-article:6378753 | pubmed:author | pubmed-author:MacbethF RFR | lld:pubmed |
| pubmed-article:6378753 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6378753 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:6378753 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6378753 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6378753 | pubmed:pagination | 179-88 | lld:pubmed |
| pubmed-article:6378753 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:meshHeading | pubmed-meshheading:6378753-... | lld:pubmed |
| pubmed-article:6378753 | pubmed:articleTitle | A report on a prospective trial of no initial therapy in patients with initial therapy in patients with asymptomatic favourable prognosis non-Hodgkin's lymphoma. | lld:pubmed |
| pubmed-article:6378753 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6378753 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:6378753 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6378753 | lld:pubmed |
